July 1 - Bayer said it will consolidate its U.S. glyphosate business under its Ruveon unit, a decision disclosed one day after the company petitioned U.S. officials to impose tariffs on glyphosate imports from China. Bayer described the transition as part of a broader five-year restructuring plan within its Crop Science division.
The company said the new arrangement keeps the business within Bayer's ownership but places responsibility for all U.S. glyphosate activities inside the St. Louis-based Ruveon operation. Ruveon will oversee pricing, go-to-market strategies, production and logistics for the chemical that serves as the active ingredient in Roundup.
Bayer noted that it is the only remaining U.S. producer of glyphosate and that it has characterized the current domestic glyphosate business as unsustainable, using the phrase, "the domestic glyphosate business as it stands today is not sustainable." That assessment and the request for duties on Chinese imports have provoked opposition among some farmers, who said the combination of consolidation and trade measures would increase herbicide costs.
Corporate communications from Bayer framed the consolidation as a means of creating a business unit better suited to operate in a commodity-oriented market. In its statement, Bayer said, "Ruveon is expected to be a more nimble and well-positioned player within its commodity-based market, which requires a specialized approach to address competitive dynamics."
The company also confirmed leadership for the new unit, naming long-time Bayer executive Alfonso Alba Ordonez as Ruveon's head. Bayer emphasized that while Ruveon will act with greater specialization, it remains a Bayer business.
The announcement follows recent legal developments for the company. Last week the U.S. Supreme Court blocked thousands of state-court lawsuits that had accused Bayer of failing to warn users that glyphosate causes cancer, a decision the company described as a major legal victory.
Officials said the reorganization is intended to align the glyphosate operations with the strategic targets of the Crop Science restructuring plan over five years, giving Ruveon responsibility for the full commercial and operational footprint of the U.S. glyphosate business.
Summary
Bayer is consolidating its U.S. glyphosate activities into Ruveon following a petition for duties on Chinese imports. The move, part of a five-year Crop Science restructuring plan, transfers pricing, market strategy, production and logistics oversight to Ruveon, which will be led by Alfonso Alba Ordonez. Farmers have objected to the duties request, warning it would raise herbicide costs. The restructuring comes as Bayer secured a U.S. Supreme Court ruling blocking thousands of state-court lawsuits linked to glyphosate.